Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

ID
13851311000001109
Virtual product
Thalidomide 50mg capsules
Name
Thalidomide BMS 50mg capsules
Description
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
Date of name applicability
1 Nov 2022
Previous Name
Thalidomide Celgene 50mg capsules
Supplier
Bristol-Myers Squibb Pharmaceuticals Ltd
Licensed as
Medicines - MHRA/EMA
Restrictions on availability
None
Licensed route
Oral